The SARS-CoV-2 spike protein has a DNA sequence identical to a genetic code patented by Moderna three years before the C-19 outbreak in 2016.
One study shared in Frontiers in Virology reveals that the SARS-CoV-2 furin cleavage site has a tiny bit of genetic code identical to a part of a gene patented by Moderna in 2016.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The researchers stated that there was one in three trillion chance Moderna’s patented sequence randomly appeared in natural evolution, that the China virus maybe has mutated in the experiments on human cells in a lab.
“The absence of CTCCTCGGCGGGCACGTAG from any eukaryotic or viral genome in the BLAST database makes recombination in an intermediate host an unlikely explanation for its presence in SARS-CoV-2,” the scientists wrote.
Moderna’s patented sequence is a segment of a gene called MSH3, compromised of about 3,300 units of genetic code known as nucleotides.
“The presence in SARS-CoV-2 of a 19-nucleotide RNA sequence encoding an FCS at amino acid 681 of its spike protein with 100% identity to the reverse complement of a proprietary MSH3 mRNA sequence is highly unusual,” the researchers noted.
Professor Lawrence Young called this revelation a ‘’quirky’’ coincidence that doesn’t prove that the virus is artificially made.
“We’re talking about a very, very, very small piece made up of 19 nucleotides,” Young said. “So it doesn’t mean very much, to be frank, if you do these types of searches, you can always find matches.”
“It’s a quirky observation, but I wouldn’t call it a smoking gun because it’s too small,” he added.
Hungarian scientists discovered “traces of a unique variant of coronavirus while examining DNA from soil from Antarctica that had been sent to the firm Sangon Biotech in Shanghai,” the Daily Mail reported.
“The researchers also found genetic material from Chinese hamsters and green monkeys, which may suggest the virus was being examined in a lab, using either the animals themselves or their cells.”
Pfizer CEO Albert Bourla confessed that his company’s mRNA vaccine was developed based on a laboratory-made version of SARS-CoV-2 rather than a naturally occurring coronavirus.
“The data that we received are data that they got from what we call a pseudovirus, so it’s not the real virus, it is a virus that we have constructed in our labs, and it is identical with the Omicron virus,” Bourla said.
See the study:
Watch the video below: